Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy.
about
Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men.Self-loathing aspects of depression reduce postoperative opioid cessation rateMorphine attenuates testosterone response to central injection of kisspeptin in male rats.Methadone induces testosterone suppression in patients with opioid addiction.Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunctionCanadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.Interactions of morphine and Peptide 234 on mean plasma testosterone concentration.Opioids in chronic noncancer pain.When and when not to use testosterone for palliation in cancer care.A systematic review of opioid effects on the hypogonadal axis of cancer patients.Chronic opioid therapy in long-term cancer survivors.The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).Intrathecal Opioid Therapy for Non-Malignant Chronic Pain: A Long-Term Perspective.Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic.Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 1: population en général.Q56776799
P2860
Q33845713-E6C64B49-2CFC-4457-AC68-FA14C6B6C583Q33851745-9013F76D-DDF5-4158-B7DC-B23C247CB090Q33937300-58F84AD8-B897-42F3-BDE0-507A0DC52DE0Q34085814-B17BE8D3-5175-483D-99BF-C8D577C0478CQ35508699-6B96F5EA-602F-435E-8970-769A837E7A4BQ35548497-2D6AF9B3-EE23-4794-AF68-F24718AA2204Q37671178-325913AE-76F4-4822-A341-A9E671E07E5BQ37737304-B326B13B-2274-47B7-8E23-0A5DB44CDDBBQ38186655-E13402F1-A2B5-4FBE-BFF1-651F266D8DE8Q38196329-E9C30636-AECE-4655-8C1F-920FEE051589Q38904553-0545014B-F699-4A44-AE6A-86977FA5B661Q39280821-CC930E9E-9576-47B0-9891-BE5223228AABQ39340051-13A2A41D-DBD1-4899-8CB7-D8CFE3B56817Q43075740-FB4C7482-CFBF-4F06-B281-0709041C471BQ44334071-A04EDD83-F53C-4024-BA92-69443D026247Q45871147-EBB017FD-3963-4CEF-8314-671175800445Q56776799-353ED292-6A48-4B4C-B269-F925CEE6F177
P2860
Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@en
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@nl
type
label
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@en
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@nl
prefLabel
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@en
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@nl
P2093
P1476
Hypogonadism and sexual dysfun ...... eiving chronic opioid therapy.
@en
P2093
Arun Rajagopal
Guddi Kaur
J Lynn Palmer
Rena Vassilopoulou-Sellin
P304
P356
10.1016/S0885-3924(03)00331-2
P577
2003-11-01T00:00:00Z